| Literature DB >> 25019413 |
Alexis Rodríguez1, Elba Villegas2, Alejandra Montoya-Rosales3, Bruno Rivas-Santiago3, Gerardo Corzo4.
Abstract
The contention and treatment of Mycobacterium tuberculosis and other bacteria that cause infectious diseases require the use of new type of antibiotics. Pandinin 2 (Pin2) is a scorpion venom antimicrobial peptide highly hemolytic that has a central proline residue. This residue forms a structural "kink" linked to its pore-forming activity towards human erythrocytes. In this work, the residue Pro14 of Pin2 was both substituted and flanked using glycine residues (P14G and P14GPG) based on the low hemolytic activities of antimicrobial peptides with structural motifs Gly and GlyProGly such as magainin 2 and ponericin G1, respectively. The two Pin2 variants showed antimicrobial activity against E. coli, S. aureus, and M. tuberculosis. However, Pin2 [GPG] was less hemolytic (30%) than that of Pin2 [G] variant. In addition, based on the primary structure of Pin2 [G] and Pin2 [GPG], two short peptide variants were designed and chemically synthesized keeping attention to their physicochemical properties such as hydrophobicity and propensity to adopt alpha-helical conformations. The aim to design these two short antimicrobial peptides was to avoid the drawback cost associated to the synthesis of peptides with large sequences. The short Pin2 variants named Pin2 [14] and Pin2 [17] showed antibiotic activity against E. coli and M. tuberculosis. Besides, Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 µM, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration. Furthermore, these short antimicrobial peptides had better activity at molar concentrations against multidrug resistance M. tuberculosis than that of the conventional antibiotics ethambutol, isoniazid and rifampicin. Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25019413 PMCID: PMC4096598 DOI: 10.1371/journal.pone.0101742
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Physicochemical properties of Pin2 and Pin2 variants.
| Molecular Weight (Da) | ||||||||
| Peptide | Sequence | GRAVY | AMF | μHrel | Q | RT (min) | Theoretical | Experimental§ |
|
| FWGALAKGALKLIPSLFSSFSKKD | 0.329 | 0.4283 | 0.48 | +3 | 30.6 | 2612.1 | 2612.0 |
|
| FWGALAKGALKLIGSLFSSFSKKD | 0.379 | 0.4296 | 0.49 | +3 | 40.1 | 2572.0 | 2572.0 |
|
| FWGALAKGALKLIGPGSLFSSFSKKD | 0.273 | 0.4369 | 0.28 | +3 | 27.6 | 2726.2 | 2727.0 |
|
| FWGLKGLKKFSKKL | −0.357 | 0.4271 | 0.51 | +5 | 18.5 | 1680.1 | 1680.0 |
|
| FWGLKGLKGPGKFSKKL | −0.435 | 0.4453 | 0.35 | +5 | 17.2 | 1891.3 | 1891.3 |
GRAVY, Sequence Grand average of hydropathicity, calculated using the Expasy ProtParam tool ( http://web.expasy.org/protparam/ ), according to Kyte and Doolittle, 1982 .
AMF, Average Molecular Flexibility values were calculated according to Liu ., 2008 .
μHrel, Relative Hydrophobic Moment, a value of 0.5 thus indicates that the peptide has about 50% of the maximum possible amphipathicity. Calculated using HydroCalc ( http://www.bbcm.univ.trieste.it/~tossi/HydroCalc/HydroMCalc.html ).
Q, Net charge.
RT, Retention Time in minutes.
(§)Mass Spectrometry, ESI-MS (Finnigan LCQ
Figure 1Helical wheel diagrams of Pin2 and Pin2 variants.
Helical wheels were prepared by the software Helical Wheel Projections [56]. The hydrophobic residues are colored in black, hydrophilic and neutral residues are colored in white. A. Pin2, B. Pin2 [G], C. Pin2 [GPG], D. Pin2 [14] and E. Pin2 [17].
Alignment of the sequences of Pin2 [14] and Pin2 [17] with the sequence of other antimicrobial peptides.
| Peptide | UniProtKB ID | Origin | Sequence | AA | Identity (%) | Q | Reference |
| Pin2 | - | Synthetic |
| 14 | - | +5 | This work |
| Pin2 | P83240 |
|
| 24 | 50.0 | +3 |
|
| CPF-SE3 | P84386 |
|
| 18 | 50.0 | +3 |
|
| CE-MA | - | Synthetic |
| 17 | 47.4 | +7 |
|
| Macropin 1 |
|
| 13 | 47.1 | +3 |
| |
| Mastoparam | P69034 |
|
| 14 | 47.1 | +3 |
|
| Japonicin 1 | B3VZU2 |
|
| 14 | 46.7 | +3 |
|
| Pin2 | Synthetic |
| 17 | - | +5 | This work | |
| Pin2 | P83240 |
|
| 24 | 54.2 | +3 |
|
| Ponericin W5 | P82427 |
|
| 24 | 50.0 | +5 |
|
| CPF-SE3 | P84386 |
|
| 18 | 47.6 | +3 |
|
| NRC-15 | - |
|
| 21 | 47.6 | +2 |
|
| Brevinin 1RTb | D1MIZ6 |
|
| 24 | 45.8 | +4 |
|
| Brevinin 1AUa | - |
|
| 24 | 44.0 | +4 |
|
| Maxinin H39 | Q58T55 |
|
| 20 | 42.9 | +2 |
|
, The sequence alignment was obtained using the on line program ClustawlW2 ( http://www.ebi.ac.uk/Tools/msa/clustalw2/ ).
AA, Number of amino acids.
Identity (%), sequence identity in percentage.
Q, Net Charge.
§, Cecropin A (residues 1–8)/Magainin 2b (residues 4–12) hybrid.
Figure 2RP-HPLC purification of Pin2 and the variants characterized in this report.
A. Pin2, B. Pin2 [G], C. Pin2 [GPG], D. Pin2 [14] and E. Pin2 [17].
Figure 3Circular dichroism of Pin2 and its long and short variants at different concentrations of TFE.
A. CD spectra of Pin2, Pin2 [G] and Pin2 [GPG] at 60% TFE, B. Pin2, C. Pin2 [G], D. Pin2 [GPG], E. Pin2 [14], F. Pin2 [17].
Antimicrobial and hemolytic activities of Pin2 and the Pin2 variants.
| MIC (µM) | ||||
| Peptide | Assay |
|
| Hemolysis (IC50) |
| Pin2 | MHA | 18.8 | 37.5 | 3.3 [1.9–5.7] |
| MHB | 12.5 | 12.5 | ||
| Pin2 [G] | MHA | 12.5 | 12.5 | 1.4 [0.4–4.3] |
| MHB | 12.5 | 12.5 | ||
| Pin2 [GPG] | MHA | 25 | 25 | 46.6 [34–64] |
| MHB | 12.5 | 12.5 | ||
| Pin2 | MHA | 25 | >300 | 418.4 [291–602] |
| MHB | 25 | >25 | ||
| Pin2 | MHA | 25 | 80 | NO |
| MHB | >25 | >25 | ||
MHA, Mueller-Hinton Agar.
MHB: Mueller Hinton Broth.
Mean and 95% confidence intervals, values expressed in µM.
*The numeric IC50 value was obtained from the Boltzmann sigmoid equation fit.
Bacteriostatic effect.
NO means no observed hemolytic activity at 100 µM.
Figure 4Antimicrobial activity of the Pin2 variants against E. coli ATCC 25922 and S. aureus ATCC 25923.
E. coli antimicrobial activity, A. Pin2 [G], B. Pin2 [GPG], C. Pin2 [14], and D. Pin2 [17]. S. aureus antimicrobial activity, E. Pin2 [G], F. Pin2 [GPG], G. Pin2 [14], and H. Pin2 [17]. The concentration of peptides used was from 0.4 to 25 µM (n = 3).
Antimicrobial activity of Pin2 and the Pin2 variants on two strains of M. tuberculosis.
|
|
| ||||
| Peptide | MW (Da) | MIC (µg/mL) | MIC (µM) | MIC (µg/mL) | MIC (µM) |
| Pin2 | 2,612.1 | 57.7±22.3 | 22.1±8.6 | 86.5 | 33.1 |
| Pin2 [G] | 2,572.0 | 48.1 | 18.7 | 48.1 | 18.7 |
| Pin2 [GPG] | 2,762.2 | 80.1±24.8 | 29±9 | 48.1 | 17.4 |
| Pin2 | 1,680.1 | 20±6.2 | 11.92±3.7 | 10±3.1 | 6±1.8 |
| Pin2 | 1,891.3 | 22±4.9 | 11.65±2.59 | 28.0±9.8 | 14.8±5.2 |
| Ethambutol | 204.3 | 0.5 | 2.5 | 20 | 97 |
| Isoniazid | 137.1 | 24±8.8 | 175.1±63.9 | 6±2.2 | 43.8±16 |
| Rifampicin | 823.0 | 0.4 | 0.5 | 32 | 38.9 |
The MIC values were calculated using the Resazurin dye reduction method, 500,000 bacteria per well were evaluated.
§, MIC values reported by Rastogi, et al., 1996 [55] .
*, Clinically isolated strain characterized with resistance to rifampicin and isoniazid in UIMZ-IMSS, Zacatecas, Mexico.
Figure 5Hemolytic activity in human red blood cells.
Data are the average of at least four independent experiments. Error bars represent the standard deviations.